I had a fantastic time at the Microbiology Society Conference this week in Liverpool. I presented my research on Nipah antivirals, marking my final presentation as a postdoc at @Carroll_Lab_Ox A great way to close this chapter- excited for the next adventure! #microsoc
Talks - Tuesday 1st April
Screening FDA-Approved drugs with recombinant Cedar virus as a CL-2 surrogate to identify potential Nipah virus antivirals by @EmilyCVirology - Tuesday 1st April @ 14:57, Hall 11B
Last week I graduated with my PhD from @LancasterUni 🎓
I had a great time celebrating with family and friends, and graduating alongside my sister @leahclaytonn who received the Chancellor’s medal!
What a way to wrap up 6 years spent at Lancaster! 🌹
#PhDone#Graduation
Yesterday I had the pleasure in taking part in Nipah Day at the @PSIOxford whereby I presented a talk on my current project: Screening of FDA-approved Compounds Using a Recombinant Cedar virus to Improve Nipah Treatment Options.
@Carroll_Lab_Ox@gatesfoundation#nipah#cedar 💊🦠
Check out this paper published in our special issue!
@Loeffler_News
Viruses | Free Full-Text | Rousettus aegyptiacus Fruit Bats Do Not Support Productive Replication of Cedar Virus upon Experimental Challenge https://t.co/Oz64NynUsZ
New PhD position available with us and @dstlmod: Characterising the host-pathogen interaction of henipaviruses
The student will have the opportunity to use in vivo samples and organoids to study the neurological pathology of henipaviruses
Please share! https://t.co/Ram3MHkF7U
Pleased to be presenting a poster on my research titled ‘High-throughput screening of FDA-approved compounds using a Recombinant Cedar Virus Platform for Henipavirus Antiviral Discovery’ here at the Microbiology Conference 2024 in Edinburgh. Catch me at poster stand A367 today🦇
Very pleased to share our recent paper highlighting the role of the IFIT5 gene in bats. This work was undertaken during my PhD at Lancaster whereby I explored bat innate immunity and their roles as viral reservoirs.
https://t.co/fpFDtduf7Y
UKHSA has detected a single confirmed human case of influenza A(H1N2)v, which is the first detection of this strain of flu in a human in the UK. We are monitoring the situation closely.
Read more in our news story: https://t.co/TqZ3kt1uEG